Suchergebnisse - "Weber, Jeffrey"

PubPharm (567)

1

State-Of-The-Art Advancements on Cancer Vaccines and Biomarkers

enthalten in: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting | 2024

von Strum, S. | Andersen, M. | Svane, I. | +2

2

Gut microbiome is associated with recurrence-free survival in patients with resected Stage IIIB-D or Stage IV melanoma treated with immune checkpoint inhibitors

enthalten in: bioRxiv.org | 2024

von Usyk, M. | Hayes, R. | Knight, R. | +5

3

Gut microbiome is associated with recurrence-free survival in patients with resected Stage IIIB-D or Stage IV melanoma treated with immune checkpoint inhibitors

enthalten in: bioRxiv : the preprint server for biology | 2024

von Usyk, M. | Hayes, R. | Knight, R. | +5

4

ENHANCED EXPANSION OF TUMOR-INFILTRATING LYMPHOCYTES FOR ADOPTIVE CELL THERAPY

enthalten in: Europäisches Patentamt | 2024

von SARNAIK AMOD A | WEBER JEFFREY S | PILON-THOMAS SHARI | +3

5

Author Correction : Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial

enthalten in: Nature medicine | 2024

von Kirkwood, J. | Del Vecchio, M. | Weber, J. | +18

ErratumFor: Nat Med. 2023 Nov;29(11):2835-2843. - PMID 37845511

6

Plain language summary of the CheckMate 76K study results : nivolumab given after stage 2B/2C melanoma is removed by surgery

enthalten in: Future oncology (London, England) | 2024

von Kirkwood, J. | Vecchio, M. | Weber, J. | +18

7

How Far We've Come

enthalten in: Cancer journal (Sudbury, Mass.) | 2024

von Sznol, M. | Weber, J.

8

Melanoma-Modern Treatment for Metastatic Melanoma

enthalten in: Cancer journal (Sudbury, Mass.) | 2024

von Dimitrova, M. | Weber, J.

9

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942) : a randomised, phase 2b study

enthalten in: Lancet (London, England) | 2024

von Weber, J. | Carlino, M. | Khattak, A. | +31

10

Publisher Correction : Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial

enthalten in: Nature medicine | 2024

von Kirkwood, J. | Del Vecchio, M. | Weber, J. | +18

ErratumFor: Nat Med. 2023 Nov;29(11):2835-2843. - PMID 37845511

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[57]